Extraintestinal Clostridioides difficile infection

被引：0

作者：

Zhao, Hai ^{[1
]}

Zhen, Lei Peng ^{[2
]}

Ma, Juan ^{[1
]}

Fan, Yang ^{[3
]}

Cang, Jin Rong ^{[1
]}

Liang, Jing Yao ^{[4
]}

Zhang, Li Xia ^{[1
]}

机构：

[1] Shaanxi Prov Peoples Hosp, Clin Lab Dept, Xian, Shaanxi, Peoples R China

[2] Shaanxi Prov Peoples Hosp, Dept Orthoped, Xian, Shaanxi, Peoples R China

[3] Shaanxi Prov Peoples Hosp, Dept Dermatol, Xian, Shaanxi, Peoples R China

[4] Chang Zhi Med Coll, Med Lab & Examinat Dept, Chang Zhi City, Shanxi, Peoples R China

来源：

IDCASES | 2020年 / 22卷

关键词：

Clostridioides (clostridium) tissue infection infectious control;

D O I：

10.1016/j.idcr.2020.e00921

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Clostridioides (Clostridium) difficile is the major cause of healthcare antibiotic-associated diarrhoea. However, extra-intestinal manifestations of Clostridioides (Clostridium) difficile infection (CDI) (including bacteremia and tissue infection) are extremely rare. We report a case of extraintestinal CDI after surgery. The isolate of C. difficile was not the PCR ribotype 027. However, this isolate produced toxins A and B. The patient underwent a follow-up examination 30 days after discharge, which showed complete recovery. This case report adds to existing knowledge of CDI. (c) 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

引用

页数：3

共 14 条

[1] Abreu Y, 2019, REV GASTROENTEROL ME
[2] Burke KE, 2014, GUT LIVER, V8, P1, DOI [10.5009/gnl.2014.8.1.1, 10.5009/gn1.2014.8.1.1]
[3] The role of toxins in Clostridium difficile infection
Chandrasekaran, Ramyavardhanee
Lacy, D. Borden
[J]. FEMS MICROBIOLOGY REVIEWS, 2017, 41 (06) : 723 - 750
[4] Czepiel J., 2019, Eur. J. Clin. Microbiol. Infect. Dis, P1
[5] Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure
Johnson, Steven W.
Brown, Shannon, V
Priest, David H.
[J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (05) : 1133 - 1139
[6] Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials
Johnson, Stuart
Louie, Thomas J.
Gerding, Dale N.
Cornely, Oliver A.
Chasan-Taber, Scott
Fitts, David
Gelone, Steven P.
Broom, Colin
Davidson, David M.
[J]. CLINICAL INFECTIOUS DISEASES, 2014, 59 (03) : 345 - 354
[7] Fecal Microbiota Transplantation for Primary Clostridium difficile Infection
Juul, Frederik E.
Garborg, Kjetil
Bretthauer, Michael
Skudal, Hilde
Oines, Mari N.
Wiig, Havard
Rose, Oystein
Seip, Birgitte
Lamont, J. Thomas
Midtvedt, Tore
Valeur, Jorgen
Kalager, Mette
Holme, Oyvind
Helsingen, Lise
Loberg, Magnus
Adami, Hans-Olov
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (26) : 2535 - +
[8] Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500
[9] Clostridium difficile Infection
Leffler, Daniel A.
Lamont, J. Thomas
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (16) : 1539 - 1548
[10] Lessa FC, 2015, NEW ENGL J MED, V372, P2369, DOI [10.1056/NEJMc1505190, 10.1056/NEJMoa1408913]

← 1 2 →